Treatments used in complementary and alternative medicine

Side Effects of Drugs Annual

Volumn 33, Issue 1, 2011, Pages 989-1007

  Chan, K ^a   Zhang, H W ^a   Lin, Z X ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82255163340     PISSN: 03786080     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53741-6.00048-9     Document Type: Chapter

References (133)

1. Menniti-Ippolito F., Mazzanti G., Santuccio C., Angela Moro P., Calapai G., Firenzuoli F., Valeri A., Raschetti R. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf 2008, 17(6):626-635.
2. Wang H., Ye X., Gao Q., Wu C., Qian Y., Luo B., Sun Y., He J. Pharmacovigilance in traditional chinese medicine safety surveillance. Pharmacoepidemiol Drug Saf 2009, 18(5):357-361.
3. Cheng C.W., Bian Z.X., Li Y.P., Moher D., Wu T.X., Dagenais S., Li J., Li T.Q. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials. Zhong Xi Yi Jie He Xue Bao 2008, 6(9):881-886.
4. Jose J., Rao P.G., Kamath M.S., Jimmy B. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital. J Altern Complement Med 2009, 15(7):793-797.
5. Jia J.R., Li B.F. One case of allergic reaction caused by orally taking Ling yang gan mao capsule. Chin Med 2009, 4(6):480.
6. Du Z.Y. Two cases of allergic exfoliative dermatitis caused by taking shen ling bai zhu san. Chin Commun Doc 2008, 10(198):159-160.
7. Li C.R., Xu L., Qiu J.M. One case of liver damage caused by zhi xue capsule. Chin J Pharmacovigil 2009, 6(11):687.
8. State Food and Drug Administration Chinese Adverse Drug Reaction Information Bulletin 2008 2008, [Notice on the liver damage caused by zhi xue capsule.]. http://www.sfda.gov.cn/WS01/CL0304/33571.html.
9. State Food and Drug Administration Chinese Adverse Drug Reaction Information Bulletin 2008 2008, 16. [Warnings on the liver damage caused by Zhuang gu guan jie wan.]. http://www.sda.gov.cn/WS01/CL0078/32614.html.
10. Song X.J. One case of liver damage caused by zhuang gu guan jie wan. Chin Foreign Med 2009, 28(18):181.
11. Zhou K., Dai Z., Liu Z.B., Tan Y., Hu L.M., et al. Experimental study of screening the hepatotoxic medicinal materials in zhuang gu guan jie pill. Chin J Pharmacovigil 2009, 6(11):641-648.
12. Gong S.Y., Shi C.S. One case of allergic reaction to the Ci Wu Jia injection. Pract Pharma Clin Rem 2008, 11(5):284.
13. Yuan L.Y. One case of hypersensitive reactions caused by Chinese medicine preparation of Ku Die Zi injection. Baotou Med 2009, 33(4):252.
14. Jiang Z., Tan H.H., Luo L.N. Two cases of acute kidney failure caused by Lian Bi Zhi injection. Med J Chin Peoples Armed Police Forces 2009, 20(6):546.
15. Wang D.F., Hu J.J., Xu Z.Y., Zhang X.L., Ji L.J. One case report of acute kidney damage caused by Lian Bi Zhi injection. Chin J Integr Tradit West Med Intensive Crit Care 2009, 16(1):55.
16. State Food and Drug Administration Chinese Adverse Drug Reaction Information Bulletin 2005 2005, 8. [Lian Bi Zhi injection and acute kidney damage.]. http://www.sda.gov.cn/WS01/CL0078/11280.html.
17. Fang Q., Bo D.H., Zhang G.F. Four cases of adverse effects caused by Shu Xue Ning injection. Capital Med 2009, (16):55.
18. Liao Y.H. Two cases of allergic reactions caused by Shu Xue Ning injection. Health Med Res Pract 2008, 5(4):92.
19. Wang S.X. One case of anaphylactic shock caused by Shu Xue Ning injection. Chin J Pharmacovigil 2009, 6(3):180.
20. Xie R.M., Zhou S.P. One case of anaphylactic shock caused by Shu Xue Ning injection. Chin Gen Nur 2009, 7(165):3383.
21. Dong C.X. Two cases of adverse effects caused by Xing Nao Jing injection. Qilu Pharm Aff 2009, 28(12):757.
22. State Food and Drug Administration Chinese Adverse Drug Reaction Information Bulletin 2004 2004, 7. [Adverse effects of Zedoary Turmeric oil injection.]. http://www.sda.gov.cn/WS01/CL0078/11279.html.
23. Li B., Chang Y.H., Ma X.N. The analysis of 5 cases of adverse effects in pediatric caused by Zedoary Turmeric oil injection. Chin Med Herald 2009, 6(31):109.
24. Ravi Raja A., Vishal Babu G.N., Geralding Menezes, Venkatesh T. Lead toxicity as a result of herbal medication. Indian J Clin Biochem 2008, 23(2):200-203.
25. Borrelli F., Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008, 199(5):455-466.
26. Pierard S., Coche J.C., Lanthier P., Dekoninck X., Lanthier N., Rahier J., Geubel A.P. Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur J Gastroenterol Hepatol 2009, 21(8):941-945.
27. Vannacci A., Lapi F., Gallo E., Vietri M., Toti M., Menniti-Ippolito F., Raschetti R., Firenzuoli F., Mugelli A. A case of hepatitis associated with long-term use of Cimicifuga racemosa. Altern Ther Health Med 2009, 15(3):62-63.
28. Mahady G.B., Low Dog T., Barrett M.L., Chavez M.L., Gardiner P., Ko R., Marles R.J., Pellicore L.S., Giancaspro G.I., Sarma D.N. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008, 15(4 Pt 1):628-638.
29. European Medicines Agency Assessment of case reports connected to herbal medicinal products containing. Cimicifugae racemosae rhizome 2007, (black cohosh, root). 8 May. http://www.emea.europa.eu/pdfs/human/hmpc/26925806en.pdf.
30. Medicines and Healthcare products Regulatory Agency MHRA action on safety concerns over black cohosh and liver injury 2006, Press release. 18 July, 2006. http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON2024116?ssSourceNodeId=663.
31. Australian Therapeutic Goods Administration New labeling and consumer information for medicines containing black cohosh (Cimicifuga racemosa) 2006, http://www.tga.gov.au/cm/0705blkcohosh.htm.
32. Natural Health Products Directorate Black cohosh; 2007. 2007, http://www.hc-sc.gc.ca/dhp-mps/alt%20formats/hpfb-dgpsa/pdf/prodnatur/mono%20cohosh-grappes%20e.pdf.
33. Nasr A., Nafeh H. Influence of black cohosh (Cimicifuga racemosa) use by postmenopausal women on total hepatic perfusion and liver functions. Fertil Steril 2009, 92(5):1780-1782.
34. Teschke R., Schwarzenboeck A. Suspected hepatotoxicity by Cimicifugae racemosae rhizoma (black cohosh, root): critical analysis and structured causality assessment. Phytomedicine 2009, 16(1):72-84.
35. Teschke R., Bahre R., Fuchs J., Wolff A. Black cohosh hepatotoxicity: quantitative causality evaluation in nine suspected cases. Menopause 2009, 16(5):956-965.
36. Teschke R., Bahre R., Genthner A., Fuchs J., Schmidt-Taenzer W., Wolff A. Suspected black cohosh hepatotoxicity-challenges and pitfalls of causality assessment. Maturitas 2009, 63(4):302-314.
37. Agbabiaka T.B., Savović J., Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf 2008, 31(1):21-37.
38. Gravas S., Tzortzis V., Rountas C., Melekos M.D. Extracorporeal shock-wave lithotripsy and garlic consumption: a lesson to learn. Urol Res 2010, 38(1):61-63.
39. Kim H.K., Kim J.S., Cho Y.S., Park Y.W., Son H.S., Kim S.S., Chae H.S. Endoscopic removal of an unusual foreign body: a garlic-induced acute esophageal injury. Gastrointest Endosc 2008, 68(3):565-566.
40. Al-Qattan M.M. Garlic burns: case reports with an emphasis on associated and underlying pathology. Burns 2009, 35(2):300-302.
41. Rao P.P., Shetty B.S., ShameemShah K., Kumaraswamy M., Kamath G.S., Ullasa S. "Garlic burns due to naturopathic folk remedy" -an emphasis on its elimination. Burns 2009, 35(4):612.
42. Yun S.K., Kim S.M., Park J., Lee J.S., Yi J.H., Kim H.U., Ihm C.W. Large superficial basal cell carcinoma arising from moxa cautery. Eur J Dermatol 2009, 19(4):387-388.
43. Horoz M., Gok E., Genctoy G., Ozcan T., Olmaz R., Akca M., Kiykim A., Gurses I. Crataegus orientalis associated multiorgan hypersensitivity reaction and acute renal failure. Intern Med 2008, 47(23):2039-2042.
44. Chen J.C., Qiu M.S., Xu M. One case of acute renal failure caused by taking large dose of herba cynomorii. Trad Chin Med J 2008, 7(2):46-47.
45. Suk S.H., Kwak Y.T. Toxic encephalopathy after taking dried seeds of Datura stramonium in two elderly subjects. Geriatr Gerontol Int 2009, 9(3):326-328.
46. Keleş E., Yalçin S., Alpay H.C., Tazegül A. Septum perforation due to the use of Ecbalium elaterium. Int J Clin Pract 2009, 63(5):826-827.
47. Kokkonouzis I., Antoniou G. Images in emergency medicine. Uvular oedema caused by intranasal aspiration of undiluted juice of Ecbalium elaterium. Emerg Med J 2009, 26(8):566.
48. Herrera S., Bruguera M. Hepatotoxicidad inducida por el uso de hierbas y medicamentos para perder peso. [Hepatotoxicity induced by herbs and medicines used to induce weight loss.]. Gastroenterol Hepatol 2008, 31(7):447-453.
49. US Food and Drug Administration FDA warns consumers to stop using Hydroxycut products dietary supplements linked to one death; pose risk of liver injury 2010, http://wwwfdagov/NewsEvents/Newsroom/PressAnnouncements/ucm149575htm.
50. Stevens T., Qadri A., Zein N.N. Two patients with acute liver injury associated with use of the herbal weight-loss supplement Hydroxycut. Ann Intern Med 2005, 142(6):477-478.
51. Jones F.J., Andrews A.H. Acute liver injury associated with the herbal supplement Hydroxycut in a soldier deployed to Iraq. Am J Gastroenterol 2007, 102(10):2357-2358.
52. Shim M., Saab S. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009, 54(2):406-408.
53. Rashid N.N., Grant J. Hydroxycut hepatotoxicity. Med J Aust 2010, 192(3):173-174.
54. Sharma T., Wong L., Tsai N., Wong R.D. Hydroxycut® (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature. Hawaii Med J 2010, 69(8):188-190.
55. Chen G.C., Ramanathan V.S., Law D., Funchain P., Chen G.C., French S., Shlopov B., Eysselein V., Chung D., Reicher S., Pham B.V. Acute liver injury induced by weight-loss herbal supplements. World J Hepatol 2010, 2(11):410-415.
56. Dara L., Hewett J., Lim J.K. Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J Gastroenterol 2008, 14(45):6999-7004.
57. Lobb A. Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance. World J Gastroenterol 2009, 15(14):1786-1787.
58. Actis G.C., Bugianesi E., Ottobrelli A., Rizzetto M. Fatal liver failure following food supplements during chronic treatment with montelukast. Dig Liver Dis 2007, 39(10):953-955.
59. Fong T.L., Klontz K.C., Canas-Coto A., Casper S.J., Durazo F.A., Davern T.J.2nd, Hayashi P., Lee W.M., Seeff L.B. Hepatotoxicity: due to Hydroxycut: a case series. Am J Gastroenterol 2010, 105(7):1561-1566.
60. McDonnell W.M., Bhattacharya R., Halldorson J.B. Fulminant hepatic failure after use of the herbal weight-loss supplement Exilis. Ann Intern Med 2009, 151(9):673-674.
61. Stohs S.J., Preuss H.G., Ohia S.E., Kaats G.R., Keen C.L., Williams L.D., Burdock G.A. No evidence demonstrating hepatotoxicity associated with hydroxycitric acid. World J Gastroenterol 2009, 15(32):4087-4089.
62. Dueñas Sadornil C, Fabregas Puigtió S, Durández R. Hepatotoxicidad por Camelia sinensis. [Hepatotoxicity due to Camelia sinensis.]. Med Clin (Barc) 2004, 122:17. 677-8.
63. Bonkovsky H.L. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006, 144(1):68-71.
64. Verhelst X., Burvenich P., Van Sassenbroeck D., Gabriel C., Lootens M., Baert D. Acute hepatitis after treatment for hair loss with oral green tea extracts (Camellia Sinensis). Acta Gastroenterol Belg 2009, 72(2):262-264.
65. García-Cortés M., Borraz Y., Lucena M.I., Peláez G., Salmerón J., Diago M., Martínez-Sierra M.C., Navarro J.M., Planas R., Soria M.J., Bruguera M., Andrade R.J. Hepatotoxicidad secundaria a "productos naturales": analisis de los casos notificados al Reigstro Espanol de Hepatotoxicidad. [Liver injury induced by "natural remedies": an analysis of cases submitted to the Spanish Liver Toxicity Registry.]. Rev Esp Enferm Dig 2008, 100(11):688-695.
66. Sarma D.N., Barrett M.L., Chavez M.L., Gardiner P., Ko R., Mahady G.B., Marles R.J., Pellicore L.S., Giancaspro G.I. Low Dog T. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 2008, 31(6):469-484.
67. DeKosky S.T., Williamson J.D., Fitzpatrick A.L., Kronmal R.A., Ives D.G., Saxton J.A., Lopez O.L., Burke G., Carlson M.G., Fried L.P., Kuller L.H., Robbins J.A., Tracy R.P., Woolard N.F., Dunn L., Snitz B.E., Nahin R.L., Furberg C.D., Ginkgo Evaluation of Memory (GEM) Study Investigators Ginkgo biloba for prevention of dementia. A randomized controlled trial. JAMA 2008, 300:2253-2262.
68. Bone K.M. Potential interaction of Gingko biloba leaf with antiplatelet and anticoagulant drugs: what is the evidence?. Mol Nutr Food Res 2008, 52:764-771.
69. Wiegman D.J., Brinkman K., Franssen E.J. Interaction of Ginkgo biloba with efavirenz. AIDS 2009, 23(9):1184-1185.
70. Lundahl A., Hedeland M., Bondesson U., Knutson L., Lennernas H. The effect of St John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men. Eur J Pharm Sci 2009, 36:433-443.
71. Stadlbauer V., Weiss S., Payer F., Stauber R.E. Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with Morinda citrifolia (noni). Am J Gastroenterol 2008, 103(9):2406-2407.
72. West B.J., Su C.X., Jensen C.J. Hepatotoxicity and subchronic toxicity tests of Morinda citrifolia (noni) fruit. J Toxicol Sci 2009, 34(5):581-585.
73. Hwang S.W., Han H.S., Lim K.Y., Han J.Y. Drug interaction between complementary herbal medicines and gefitinib. J Thorac Oncol 2008, 3(8):942-943.
74. Raucy J.L. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos 2003, 31(5):533-539.
75. Lee S.H., Ahn Y.M., Ahn S.Y., Doo H.K., Lee B.C. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med 2008, 14(6):715-721.
76. Zhou X.M., Zhang H.Q. One case of allergic shock caused by sanqi pian. Clin Misdiag Misther 2009, 22(10):100.
77. Andrade A.S., Hendrix C., Parsons T.L., Caballero B., Yuan C.S., Flexner C.W., Dobs A.S., Brown T.T. Pharmacokinetic and metabolic effects of American ginseng (Panax quinquefolius) in healthy volunteers receiving the HIV protease inhibitor indinavir. BMC Complement Altern Med 2008, 8:50.
78. Yuan C.S., Wei G., Dey L., Karrison T., Nahlik L., Maleckar S., Kasza K., Ang-Lee M., Moss J. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled trial. Ann Intern Med 2004, 141(1):23-27.
79. Campagna J.A., Carter C. Clinical relevance of the Bezold-Jarisch reflex. Anesthesiology 2003, 98:1250-1260.
80. Bariş Y.I., Ozesmi M., Artvinli M. Andromedotoxin poisoning. Turk Tip Cemiy Mecm 1973, 39(8):309-322.
81. Gössinger H., Hruby K., Haubenstock A., Pohl A., Davogg S. Cardiac arrhythmias in a patient with grayanotoxin-honey poisoning. Vet Hum Toxicol 1983, 25(5):328-329.
82. Gössinger H., Hruby K., Pohl A., Davogg S., Sutterlütti G., Mathis G. Poisoning with andromedotoxin-containing honey. Dtsch Med Wochenschr 1983, 108(41):1555-1558.
83. Sütlüpinar N., Mat A., Satganoĝlu Y. Poisoning by toxic honey in Turkey. Arch Toxicol 1993, 67(2):148-150.
84. von Malottki K., Wiechmann H.W. Acute life-threatening bradycardia: food poisoning by Turkish wild honey. Dtsch Med Wochenschr 1996, 121(30):936-938.
85. Gerke R., Fahrenkrog U., Löllgen H. Syncope in a young man of Turkish origin. Internist (Berl) 2003, 44(10):1308-1312.
86. Ergun K., Tufekcioglu O., Aras D., Korkmaz S., Pehlivan S. A rare cause of atrioventricular block: mad honey intoxication. Int J Cardiol 2005, 99(2):347-348.
87. Choi S.H., Lee S.W., Hong Y.S., Lim S.I. Grayanotoxin poisoning from flower of Rhododendron mucronulatum in humans. Bull Environ Contam Toxicol 2007, 78(1):11-12.
88. Lee S.W., Choi S.H., Hong Y.S., Lim S.I. Grayanotoxin poisoning from flower of Rhododendron mucronulatum in humans. Bull Environ Contam Toxicol 2007, 78(2):132-133.
89. Dubey L., Maskey A., Regmi S. Bradycardia and severe hypotension caused by wild honey poisoning. Hellenic J Cardiol 2009, 50(5):426-428.
90. Weiss T.W., Smetana P., Nurnberg M., Huber K. The honey man-second degree heart block after honey intoxication. Int J Cardiol 2010, 142(1):e6-e7.
91. Gunduz A., Durmus I., Turedi S., Nuhoglu I., Ozturk S. Mad honey poisoning-related asystole. Emerg Med J 2007, 24(8):592-593.
92. Eller P., Hochegger K., Tancevski I., Pechlaner C., Patsch J.R. Sweet heart block. Circulation 2008, 118(3):319.
93. Choo Y.K., Kang H.Y., Lim S.H. Cardiac problems in mad-honey intoxication. Circ J 2008, 72(7):1210-1211.
94. Aliyev F., Türkoglu C., Celiker C. Nodal rhythm and ventricular parasystole: an unusual electrocardiographic presentation of mad honey poisoning. Clin Cardiol 2009, 32(11):E52-E54.
95. Cagli K.E., Tufekcioglu O., Sen N., Aras D., Topaloglu S., Basar N., Pehlivan S. Atrioventricular block induced by mad-honey intoxication: confirmation of diagnosis by pollen analysis. Tex Heart Inst J 2009, 36(4):342-344.
96. Akinci S., Arslan U., Karakurt K., Cengel A. An unusual presentation of mad honey poisoning: acute myocardial infarction. Int J Cardiol 2008, 129(2):e56-e58.
97. Koca I., Koca A.F. Poisoning by mad honey: a brief review. Food Chem Toxicol 2007, 45(8):1315-1318.
98. Geroulanos S., Attinger B., Cakmakçi M. Honey-induced poisoning. Schweiz Rundsch Med Prax 1992, 81(17):535-540.
99. Poon W.T., Ho C.H., Yip K.L., Lai C.K., Cheung K.L., Sung R.Y., Chan A.Y., Mak T.W. Grayanotoxin poisoning from Rhododendron simsii in an infant. Hong Kong Med J 2008, 14(5):405-407.
100. Humphreys D.J., Stodulski J.B. Detection of andromedotoxins for the diagnosis of Rhododendron poisoning in animals. J Appl Toxicol 1986, 6(2):121-122.
101. Weber M., Cadivel A., Chappel V., Abinaber F., Le Gallo A., Ragonneau S., Verdiere C., Lassalle C., Metas E., D'Ortenzio E. Collective intoxication with "mad honey" on Reunion Island. Bull Soc Pathol Exot 2009, 102(1):7-8.
102. Martinet O., Pommier P., Sclossmacher P., Develay A., de Haro L. Agauria salicifolia intoxication. Presse Med 2005, 34(11):797-798.
103. Ozhan H., Akdemir R., Yazici M., Gündüz H., Duran S., Uyan C. Cardiac emergencies caused by honey ingestion: a single centre experience. Emerg Med J 2004, 21(6):742-744.
104. Yilmaz O., Eser M., Sahiner A., Altintop L., Yesildag O. Hypotension, bradycardia and syncope caused by honey poisoning. Resuscitation 2006, 68(3):405-408.
105. Gunduz A., Meriçé E.S., Baydin A., Topbaş M., Uzun H., Türedi S., Kalkan A. Does mad honey poisoning require hospital admission?. Am J Emerg Med 2009, 27(4):424-427.
106. Okuyan E., Uslu A., Ozan Levent M. Cardiac effects of "mad honey": a case series. Clin Toxicol (Phila) 2010, 48(6):528-532.
107. Bostan M., Bostan H., Kaya A.O., Bilir O., Satiroglu O., Kazdal H., Karadag Z., Bozkurt E. Clinical events in mad honey poisoning: a single centre experience. Bull Environ Contam Toxicol 2010, 84(1):19-22.
108. Shrestha P., Vaidya R., Sherpa K. Mad honey poisoning: a rare case report of seven cases. Nepal Med Coll J 2009, 11(3):212-213.
109. Aliyev F., Türkoglu C., Celiker C., Firatli I., Alici G., Uzunhasan I. Chronic mad honey intoxication syndrome: a new form of an old disease?. Europace 2009, 11(7):954-956.
110. Demircan A., Keleş A., Bildik F., Aygencel G., Doĝan N.O., Gómez H.F. Mad honey sex: therapeutic misadventures from an ancient biological weapon. Ann Emerg Med 2009, 54(6):824-829.
111. Gunduz A., Turedi S., Russell R.M., Ayaz F.A. Clinical review of grayanotoxin/mad honey poisoning past and present. Clin Toxicol (Phila) 2008, 46(5):437-442.
112. Onat F.Y., Yegen B.C., Lawrence R., Oktay A., Oktay S. Mad honey poisoning in man and rat. Rev Environ Health 1991, 9(1):3-9.
113. Onat F., Yegen B.C., Lawrence R., Oktay A., Oktay S. Site of action of grayanotoxins in mad honey in rats. J Appl Toxicol 1991, 11(3):199-201.
114. Gunduz A., Turedi S., Uzun H., Topbas M. Mad honey poisoning. Am J Emerg Med 2006, 24(5):595-598.
115. Zhou F.W. One case of skin pigmentation caused by the multiglycosides Tripterygium wilfordii tablet. Med J West Chin 2009, 21(3):493.
116. López Galera R.M., Ribera Pascuet E., Esteban Mur J.I., Montoro Ronsano J.B., Juárez Giménez J.C. Interaction between cat's claw and protease inhibitors atazanavir, ritonavir and saquinavir. Eur J Clin Pharmacol 2008, 64(12):1235-1236.
117. Mohammed Abdul M.I., Jiang X., Williams K.M., Day R.O., Roufogalis B.D., Liauw W.S., Xu H., McLachlan A.J. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol 2008, 154(8):1691-1700.
118. Kung S.W., Chan Y.C., Tse M.L., Lau F.L., Chau T.L., Tam M.K. Acute renal failure and hepatitis following ingestion of carp gallbladder. Clin Toxicol 2008, 46(8):753-757.
119. Barry T.L., Petzinger G., Zito S.W. GC/MS comparison of the West Indian aphrodisiac "Love Stone" to the Chinese medication "chan su": bufotenine and related bufadienolides. J Forensic Sci 1996, 41(6):1068-1073.
120. Kostakis C., Byard R.W. Sudden death associated with intravenous injection of toad extract. Forensic Sci Int 2009, 188(1-3):e1-e5.
121. Park S.U., Ko C.N., Bae H.S., Jung W.S., Moon S.K., Cho K.H., Kim Y.S., Park J.M. Short-term reactions to acupuncture treatment and adverse events following acupuncture: a cross-sectional survey of patient reports in Korea. J Altern Complement Med 2009, 15(12):1275-1283.
122. Weidenhammer W., Streng A., Melchart D., Linde K. Adverse effects and complications of acupuncture treatment: results from a large-scale, nation-wide observational study. Dtsch Z Akupunkt 2008, 51(3):6-14.
123. Arnold A.A., Ross B.E., Silka P.A. Efficacy and feasibility of acupuncture for patients in the ED with acute, nonpenetrating musculoskeletal injury of the extremities. Am J Emerg Med 2009, 27(3):280-284.
124. Yamashita H., Tsukayama H. Safety of acupuncture practice in Japan: patient reactions, therapist negligence and error reduction strategies. Evid Based Complement Alternat Med 2008, 5(4):391-398.
125. Hong L., Chen Z., Zhou X., Han Z., Zhang X., Wu K., Fan D. Acupuncture may cause hepatotoxicity in patients in climacteric. Climacteric 2008, 11(4):345-346.
126. Chen A. Analysis of accident events in four patients after acupuncture treatment. Shanghai J Acupunct Moxib 2009, 28(2):112-113.
127. Gao Q.S., Zheng Y.J. Two cases of allergic reaction to acupuncture needle. Chin Acup Moxib 2008, 28(11):818.
128. Cassidy J.D., Boyle E., Côté P., He Y., Hogg-Johnson S., Silver F.L., Bondy S.J. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case-control and case-crossover study. Spine 2008, 33(4s):S176-S183.
129. Alcantara J., Ohm J., Kunz D. The safety and effectiveness of pediatric chiropractic: a survey of chiropractors and parents in a practice-based research network. Explore (NY) 2009, 5(5):290-295.
130. Gouveia L.O., Castanho P., Ferreira J.J. Safety of chiropractic interventions: a systematic review. Spine 2009, 34(11):E405-E413.
131. Talluri S.K., Talluri J., Besur S., Kakarala R., Klair N. Catastrophic complication of chiropractic manipulation: a report of quadriparesis. Am J Med 2009, 122(11):e3-e4.
132. Mazokopakis E.E., Karefilakis C.M., Starakis I.K. The safety and efficacy of the fruit juice of Ecballium elaterium in the treatment of acute rhinosinusitis. J Altern Complement Med 2009, 15(12):1273-1274.
133. Fontanel F., Durrieu G., Damase-Michel C., Montastruc J.L. Drug prescription and pharmacovigilance in spa therapy: a comparative study at a 20-year interval (1987 versus 2007). Therapie 2008, 63(2):135-140.